Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019

SELL
$33.0 - $60.04 $120,450 - $219,146
-3,650 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$56.15 - $73.9 $51,938 - $68,357
925 Added 33.94%
3,650 $225,000
Q2 2018

Aug 10, 2018

SELL
$47.85 - $70.45 $440,076 - $647,928
-9,197 Reduced 77.14%
2,725 $184,000
Q1 2018

May 22, 2018

SELL
$51.15 - $61.0 $21.9 Million - $26.1 Million
-427,989 Reduced 97.29%
11,922 $440,000
Q1 2018

May 21, 2018

BUY
$51.15 - $61.0 $22 Million - $26.2 Million
429,272 Added 4034.89%
439,911 $440,000
Q4 2017

Feb 14, 2018

BUY
$50.85 - $65.1 $540,993 - $692,598
10,639
10,639 $596,000

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.